雷奈酸锶致一名绝经后骨质疏松症患者发生中毒性表皮坏死松解症 - Suppr

Suppr

超能文献

Strontium ranelate-induced toxic epidermal necrolysis in a patient with post-menopausal osteoporosis.

作者信息

Lee H Y, Lie D, Lim K S, Thirumoorthy T, Pang S M

机构信息

Dermatology Unit, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore.

出版信息

Osteoporos Int. 2009 Jan;20(1):161-2. doi: 10.1007/s00198-008-0677-0. Epub 2008 Jul 4.

DOI:10.1007/s00198-008-0677-0

PMID:18600286

Abstract

摘要

相似文献

Strontium ranelate-induced toxic epidermal necrolysis in a patient with post-menopausal osteoporosis.雷奈酸锶致一名绝经后骨质疏松症患者发生中毒性表皮坏死松解症

Osteoporos Int. 2009 Jan;20(1):161-2. doi: 10.1007/s00198-008-0677-0. Epub 2008 Jul 4.

Stevens-Johnson syndrome due to strontium ranelate.雷奈酸锶所致的史蒂文斯-约翰逊综合征

Ann Acad Med Singap. 2011 Nov;40(11):510-1.

Strontium ranelate related Stevens-Johnson syndrome: a case report.雷奈酸锶相关史蒂文斯-约翰逊综合征：一例报告。

Osteoporos Int. 2014 Jun;25(6):1813-6. doi: 10.1007/s00198-014-2688-3. Epub 2014 Apr 1.

Interstitial granulomatous reaction to strontium ranelate.对雷奈酸锶的间质肉芽肿反应。

Arch Dermatol. 2008 Feb;144(2):268-9. doi: 10.1001/archdermatol.2007.54.

Generalized cutaneous drug eruption due to strontium ranelate.雷奈酸锶所致的泛发性皮肤药物疹

J Eur Acad Dermatol Venereol. 2009 Mar;23(3):321-2. doi: 10.1111/j.1468-3083.2008.02856.x. Epub 2008 Jun 23.

[Alopecia areata universalis due to strontium ranelate].[因雷奈酸锶导致的全秃]

Med Clin (Barc). 2012 Mar 3;138(5):229. doi: 10.1016/j.medcli.2011.08.002. Epub 2011 Oct 19.

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.长期雷奈酸锶治疗对绝经后骨质疏松症妇女椎骨骨折风险的影响。

Osteoporos Int. 2009 Oct;20(10):1663-73. doi: 10.1007/s00198-008-0825-6. Epub 2009 Jan 20.

Alopecia associated with strontium ranelate use in a 62-year-old woman.一位 62 岁女性使用雷奈酸锶后出现脱发。

Osteoporos Int. 2013 Mar;24(3):1127-9. doi: 10.1007/s00198-012-1979-9. Epub 2012 Apr 12.

Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.雷奈酸锶：骨质疏松症治疗新类别中的首个药物。

Adv Ther. 2008 Dec;25(12):1235-56. doi: 10.1007/s12325-008-0125-8.

Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.普罗力：对绝经后骨质疏松症的非椎骨和髋部抗骨折疗效

Bone. 2006 Feb;38(2 Suppl 1):23-7. doi: 10.1016/j.bone.2005.08.028. Epub 2006 Jan 24.

引用本文的文献

The 10th International Congress on Cutaneous Adverse Drug Reactions, Shimane, Japan, 2018: Focus on New Discoveries.第十届国际皮肤药物不良反应大会，日本岛根，2018年：聚焦新发现

Drug Saf. 2019 Jun;42(6):797-801. doi: 10.1007/s40264-019-00818-1.

Increased risk of strontium ranelate-related SJS/TEN is associated with HLA.雷奈酸锶相关的中毒性表皮坏死松解症/重症多形红斑（SJS/TEN）风险增加与人类白细胞抗原（HLA）相关。

Osteoporos Int. 2016 Aug;27(8):2577-83. doi: 10.1007/s00198-016-3568-9. Epub 2016 Mar 22.

Screening, diagnosis and treatment of osteoporosis: a brief review.骨质疏松症的筛查、诊断与治疗：简要综述

Clin Cases Miner Bone Metab. 2014 Sep;11(3):201-7.

Strontium ranelate related Stevens-Johnson syndrome: a case report.雷奈酸锶相关史蒂文斯-约翰逊综合征：一例报告。

Osteoporos Int. 2014 Jun;25(6):1813-6. doi: 10.1007/s00198-014-2688-3. Epub 2014 Apr 1.

Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.发热、皮疹和全身症状：了解病毒和 HLA 在严重皮肤药物过敏中的作用。

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):21-33. doi: 10.1016/j.jaip.2013.11.005.

Cutaneous side effects of antiosteoporosis treatments.抗骨质疏松治疗的皮肤副作用。

Ther Adv Musculoskelet Dis. 2011 Feb;3(1):31-41. doi: 10.1177/1759720X10387202.

Alopecia associated with strontium ranelate use in a 62-year-old woman.一位 62 岁女性使用雷奈酸锶后出现脱发。

Osteoporos Int. 2013 Mar;24(3):1127-9. doi: 10.1007/s00198-012-1979-9. Epub 2012 Apr 12.

Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway.果糖 1,6-二磷酸锶通过 OPG/RANKL/RANK 通路预防绝经后骨质疏松症大鼠模型的骨丢失。

Acta Pharmacol Sin. 2012 Apr;33(4):479-89. doi: 10.1038/aps.2011.177. Epub 2012 Mar 19.

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.钙、维生素 D 和抗骨质疏松药物的骨骼外获益与风险。

Osteoporos Int. 2012 Feb;23 Suppl 1(Suppl 1):S1-23. doi: 10.1007/s00198-011-1891-8. Epub 2012 Feb 4.

Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity.骨质疏松症的治疗：识别和管理皮肤不良反应和药物性超敏反应。

Osteoporos Int. 2010 May;21(5):723-32. doi: 10.1007/s00198-009-1097-5. Epub 2009 Nov 17.

本文引用的文献

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures.对全球骨质疏松性骨折的患病率及相关残疾情况的一项评估。

Osteoporos Int. 2006 Dec;17(12):1726-33. doi: 10.1007/s00198-006-0172-4. Epub 2006 Sep 16.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.雷奈酸锶用于预防和治疗绝经后骨质疏松症。

Cochrane Database Syst Rev. 2006 Jul 19(3):CD005326. doi: 10.1002/14651858.CD005326.pub2.

Strontium ranelate for the treatment of osteoporosis.

BMJ. 2005 Jun 18;330(7505):1400-1. doi: 10.1136/bmj.330.7505.1400.

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.雷奈酸锶对绝经后骨质疏松症女性椎体骨折风险的影响。

N Engl J Med. 2004 Jan 29;350(5):459-68. doi: 10.1056/NEJMoa022436.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验